Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635204 · ClinicalTrials.gov registry record · Phase 3
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
A Phase 3 study, sponsored by Promius Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 267
- Enrollment target
NCT02635204 is a Phase 3 study that has completed, run by Promius Pharma. The registered enrollment target is 267 participants.
The verdict
NCT02635204, a Phase 3 study, has completed, sponsored by Promius Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 267 participants
- Enrollment target
Study Summary
This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.
Interventions
- DRUG Vehicle Cream
- DRUG DFD06 Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02635204
The ClinicalTrials.gov registry entry for NCT02635204 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Promius Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Cream is the first listed.
NCT02635204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02635204 about?
NCT02635204 is a clinical study titled "A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis". This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.
What is the current status of trial NCT02635204?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 267 participants. The study started on 2015-12. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02635204?
The interventions under investigation include: Vehicle Cream (DRUG), DFD06 Cream (DRUG).
Who is sponsoring clinical trial NCT02635204?
This trial is sponsored by Promius Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.